Finance

Beta
Lists
2616:HKG
CStone Pharmaceuticals
HK$4.46
-5.11%
(-0.24) 1D
Jun 8, 4:09:00 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 2616...
Open
HK$4.50
High
HK$4.65
Low
HK$4.37
Mkt. cap
7.14B
Avg. vol.
12.00M
Volume
13.53M
52-wk high
HK$13.15
52-wk low
HK$3.81
EPS
-HK$0.36
No. of employees
136
Open
HK$4.50
High
HK$4.65
Low
HK$4.37
Mkt. cap
7.14B
Avg. vol.
12.00M
Volume
13.53M
52-wk high
HK$13.15
52-wk low
HK$3.81
EPS
-HK$0.36
No. of employees
136
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to 2616 in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for 2616 in the last 3 months.
Highest
Current HK$4.46
HK$9.44 (+111.66%)
Average
HK$9.44 (+111.66%)
Lowest
HK$9.44 (+111.66%)
News stories
From sources across the web
About CStone Pharmaceuticals
CEO-
Employees136
Founded2015
Headquarters-
SectorBiotechnology
Websitecstonepharma.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
24.73M
24.73M
110.07M
110.07M
Cost of goods sold
71.12M
71.12M
38.05M
38.05M
Cost of revenue
71.12M
71.12M
38.05M
38.05M
Research and development expenses
52.58M
52.58M
94.77M
94.77M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
39.60M
39.60M
46.58M
46.58M
Operating expense
92.18M
92.18M
141.35M
141.35M
Total operating expenses
163.30M
163.30M
179.40M
179.40M
Operating income
-138.58M
-138.58M
-69.33M
-69.33M
Other non operating income
4.13M
4.13M
3.45M
3.45M
EBT including unusual items
-135.09M
-135.09M
-76.88M
-76.88M
EBT excluding unusual items
-133.85M
-133.85M
-69.37M
-69.37M
Income tax expense
-
-
6.53M
6.53M
Effective tax rate
-
-
-8.50%
-8.50%
Other operating expenses
-
-
-
-
Net income
-135.09M
-135.09M
-83.41M
-83.41M
Net profit margin
-546.37%
-546.37%
-75.78%
-75.78%
Earnings per share
-
-
-
-
Interest and investment income
543.50K
543.50K
4.65M
4.65M
Interest expense
-3.45M
-3.45M
-3.18M
-3.18M
Net interest expenses
-2.91M
-2.91M
1.47M
1.47M
Depreciation and amortization charges
-
-
-
-
EBITDA
-135.51M
-135.51M
-66.41M
-66.41M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer